补语(音乐)
肾病
免疫学
补体系统
灵长类动物
医学
病毒学
生物
癌症研究
系数H
转染
非人灵长类
非人灵长类
肾小球肾炎
猿猴
抗体
经典补体途径
动物模型
免疫系统
作者
Xueyan Zhang,Xue Zhang,Qiuyu Yang,Bin Kang,Mo Dan,Chunlei Li,Yan Chen,Jianhua Gan,Xiaoye Su
标识
DOI:10.1016/j.ymthe.2026.08.022
摘要
value of 0.013 nM. In cynomolgus non-human primates, a single subcutaneous injection yielded sustained C5 suppression of over 80% for 2 months and more than 50% for up to 4 months, a duration significantly longer than is possible with existing complement inhibitors. Furthermore, we conducted a head-to-head efficacy comparison with Nefecon, an approved therapeutic agent for IgAN, in a cynomolgus monkey IgAN model. While both treatments showed comparable improvements in key renal function parameters, the C5-siRNA achieved superior pathological remission and near-complete blockade of glomerular C5 deposition and membrane attack complex formation. Collectively, this study provides a strong rationale for the clinical development of C5-siRNA as an excellent therapy for IgAN, either as a standalone monotherapy or in combination with agents targeting upstream pathogenic pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI